(Q43867242)

27 November 2017

title

Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids (English)

1 reference

27 November 2017

0 references

0 references

Jano J Janoyan

1

1 reference

27 November 2017

Jennifer L Crim

series ordinal

2

1 reference

27 November 2017

Nissar A Darmani

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Pharmacology, Biochemistry and Behavior

27 November 2017

published in

1 reference

27 November 2017

volume

71

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

155-162

1 reference

Neurobiology of marijuana abuse.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Do functional relationships exist between 5-HT1A and 5-HT2 receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

Cannabis and cannabinoids: pharmacology and rationale for clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900647-5

7 January 2021

10.1016/S0091-3057(01)00647-5

Identifiers

DOI

1 reference

27 November 2017

1 reference